Montag & Associates’s Bio-Techne TECH Stock Holding History

Montag & Associates’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.47K	Sell	21 -7	-25%	-$378	﹤0.01%	901
2026 Q1	$1.48K	Hold	28	–	–	﹤0.01%	870
2025 Q4	$1.66K	Sell	28 -3	-10%	-$182	﹤0.01%	882
2025 Q3	$1.74K	Sell	31 -2	-6%	-$107	﹤0.01%	939
2025 Q2	$1.68K	Hold	33	–	–	﹤0.01%	868
2025 Q1	$1.91K	Buy	33 +1	+3%	+$68	﹤0.01%	897
2024 Q4	$2.31K	Buy	32 +4	+14%	+$294	﹤0.01%	878
2024 Q3	$2.26K	Buy	28 +2	+8%	+$150	﹤0.01%	914
2024 Q2	$1.84K	Buy	26 +6	+30%	+$442	﹤0.01%	874
2024 Q1	$1.38K	Buy	+20	New	+$1.43K	﹤0.01%	897

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Montag & Associates's TECH Position: Q2 2026 in Review

Montag & Associates reduced its Bio-Techne (TECH) stake by 25% in Q2 2026, selling an estimated $378 and leaving 21 shares worth $1.47K. The position accounts for ﹤0.01% of the portfolio, ranked #901.

Montag & Associates first reported a position in TECH in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.31K in Q4 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Montag & Associates held 21 shares of Bio-Techne worth $1.47K as of Q2 2026.
Montag & Associates sold 7 Bio-Techne shares in Q2 2026, an estimated $378.
Bio-Techne made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #901 holding.
Montag & Associates first reported a position in Bio-Techne in Q1 2024 and has held it in 10 quarters since.
Montag & Associates's Bio-Techne position peaked at $2.31K in Q4 2024.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.